Literature DB >> 26546621

Urgent resection of a giant left atrial appendage aneurysm and mitral valve replacement in a complex case of Hurler-Scheie syndrome.

Andrew Brazier1, Ragheb Hasan1, Petra Jenkins2, Andreas Hoschtitzky1.   

Abstract

Hurler-Scheie syndrome is a rare lysosomal storage disease affecting the cardiovascular system. Besides the cardiac manifestations, it presents with complications from abnormal proteoglycan deposition in soft tissues in many locations, resulting in joint contractures, paraplegia, impaired vision, airway narrowing and restrictive lung function, to name a few. There are very few reports of surgical management of valvular heart disease due to mucopolysaccharidosis (MPS). We describe the successful management of a patient with an extremely challenging case of mitral valve stenosis and a giant left atrial appendage aneurysm due to MPS type 1 (Hurler-Scheie syndrome). The patient underwent mitral valve replacement and excision of the giant left atrial appendage aneurysm; a similar case has not been previously reported. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 26546621      PMCID: PMC4654200          DOI: 10.1136/bcr-2015-211551

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  5 in total

1.  Double-valve replacement for Scheie's syndrome subtype mucopolysaccaridosis type 1-S.

Authors:  Takashi Murashita; Junjiro Kobayashi; Yusuke Shimahara; Koichi Toda; Tomoyuki Fujita; Hiroyuki Nakajima
Journal:  Ann Thorac Surg       Date:  2011-09       Impact factor: 4.330

2.  Cardiac structural involvement in mucopolysaccharidoses.

Authors:  Donato Rigante; Giuseppe Segni
Journal:  Cardiology       Date:  2002       Impact factor: 1.869

3.  Surgical treatment for Scheie's syndrome (mucopolysaccharidosis type I-S): report of two cases.

Authors:  K Minakata; Y Konishi; M Matsumoto; S Miwa
Journal:  Jpn Circ J       Date:  1998-09

4.  Surgical treatment for mitral stenosis in Scheie's syndrome: mucopolysaccharidosis type I-S.

Authors:  Katsukiyo Kitabayashi; Goro Matsumiya; Hajime Ichikawa; Hajime Matsue; Kazuo Shimamura; Yoshiki Sawa
Journal:  Ann Thorac Surg       Date:  2007-08       Impact factor: 4.330

5.  Postmortem studies on a patient with mucopolysaccharidosis type I: histopathological findings after one year of enzyme replacement therapy.

Authors:  S Yano; K Moseley; Z Pavlova
Journal:  J Inherit Metab Dis       Date:  2009-03-27       Impact factor: 4.982

  5 in total
  4 in total

Review 1.  Surgical Management of Valvular Heart Disease in Mucopolysaccharidoses: A Review of Literature.

Authors:  Barbara A Rosser; Calvin Chan; Andreas Hoschtitzky
Journal:  Biomedicines       Date:  2022-02-04

Review 2.  Pre-operative Considerations in Adult Mucopolysaccharidosis Patients Planned for Cardiac Intervention.

Authors:  Benjamin Cross; Karolina M Stepien; Chaitanya Gadepalli; Ahmed Kharabish; Peter Woolfson; Govind Tol; Petra Jenkins
Journal:  Front Cardiovasc Med       Date:  2022-04-04

3.  Heart valve disease in Hurler-Scheie syndrome.

Authors:  María Del Carmen García Del Rey; Javier Castrodeza; Ángel Pinto; Maria Ángeles Espinosa Castro; Cecilia Muñoz Delgado; Francisco Fernández-Avilés
Journal:  Cardiol J       Date:  2022-07-12       Impact factor: 3.487

Review 4.  Congenital left atrial appendage aneurysm: A rare case report and literature review.

Authors:  Bin Wang; He Li; Li Zhang; Lin He; Jing Zhang; Cong Liu; Jing Wang; Qing Lv; Xiaoke Shang; Jinping Liu; Mingxing Xie
Journal:  Medicine (Baltimore)       Date:  2018-01       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.